Back to today’s briefing

Story perspectives

Semaglutide Demand Soars as Prescription Rules Tighten

2/6/2025

23 3

Summary

Story summary

In Yorkshire, the demand for semaglutide, known as Ozempic and Wegovy, surged to over 11,600 prescriptions monthly for diabetes, a notable increase from 9,800. Amid supply challenges, tirzepatide (Mounjaro) prescriptions skyrocketed to 116,000 in November. In response, the General Pharmaceutical Council has tightened online prescription rules to curb misuse for weight loss.

1 of 1

Story summary

In Yorkshire, the demand for semaglutide, known as Ozempic and Wegovy, surged to over 11,600 prescriptions monthly for diabetes, a notable increase from 9,800. Amid supply challenges, tirzepatide (Mounjaro) prescriptions skyrocketed to 116,000 in November. In response, the General Pharmaceutical Council has tightened online prescription rules to curb misuse for weight loss.